Cargando…

Mild Prolongation of Prothrombin Time Does Not Affect the Safety and Prognosis of Transjugular Intrahepatic Portal Shunt: Based on Real-World Data

BACKGROUND/AIMS: The aim was to investigate the safety and prognosis of transjugular intrahepatic portal shunt in patients with mildly prolonged prothrombin time. MATERIALS AND METHODS: Two hundred fifty-three patients with portal hypertension who received transjugular intrahepatic portal shunt from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bai, Yaowei, Liu, Jiacheng, Chen, Yang, Yang, Chongtu, Wang, Yingliang, Wang, Chaoyang, Ju, Shuguang, Zhou, Chen, Huang, Songjiang, Li, Tongqiang, Yao, Wei, Yao, Jinghong, Xiong, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Turkish Society of Gastroenterology 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544647/ https://www.ncbi.nlm.nih.gov/pubmed/37458392 http://dx.doi.org/10.5152/tjg.2023.22410

Ejemplares similares

The impact of thrombocytopenia on variceal bleeding in cirrhotic patients with transjugular intrahepatic portosystemic shunt
por: Chen, Yang, et al.
Publicado: (2023)

Changes and influencing factors of liver volume after transjugular intrahepatic portosystemic shunt: a retrospective cohort study
por: Bai, Yaowei, et al.
Publicado: (2023)

Dynamic changes in liver function after transjugular intrahepatic portosystemic shunt in patients with cirrhosis
por: Wang, Chaoyang, et al.
Publicado: (2022)

Effect of splenectomy on the outcomes in patients with cirrhosis receiving transjugular intrahepatic portosystemic shunt
por: Yang, Chongtu, et al.
Publicado: (2021)

Portal flow diversion based on portography is superior than puncture site in the prediction of overt hepatic encephalopathy after TIPS creation
por: Yang, Chongtu, et al.
Publicado: (2022)

Potential Benefits of Underdilation of 8-mm Covered Stent in Transjugular Intrahepatic Portosystemic Shunt Creation
por: Liu, Jiacheng, et al.
Publicado: (2021)

The combination of balloon-assisted antegrade transvenous obliteration and transjugular intrahepatic portosystemic shunt for the management of cardiofundal varices hemorrhage
por: Liu, Jiacheng, et al.
Publicado: (2020)

Apatinib Plus Camrelizumab With/Without Chemoembolization for Hepatocellular Carcinoma: A Real-World Experience of a Single Center
por: Ju, Shuguang, et al.
Publicado: (2022)

Late combination of transarterial chemoembolization with apatinib and camrelizumab for unresectable hepatocellular carcinoma is superior to early combination
por: Ju, Shuguang, et al.
Publicado: (2022)

Management of traumatic peripheral artery pseudoaneurysm: A 10-year experience at a single center
por: Wang, Yingliang, et al.
Publicado: (2022)

Donafenib-Loaded Callispheres Beads Embolization in a VX2 Liver Tumor: Investigating Efficacy, Safety, and Improvement of Tumor Angiogenesis After Embolization
por: Li, Tongqiang, et al.
Publicado: (2021)

Transjugular Intrahepatic Portosystemic Shunt for the Treatment of Portal Hypertension in Noncirrhotic Patients with Portal Cavernoma
por: Luo, Xuefeng, et al.
Publicado: (2014)

A VEGFR targeting peptide-drug conjugate (PDC) suppresses tumor angiogenesis in a TACE model for hepatocellular carcinoma therapy
por: Wang, Dongyuan, et al.
Publicado: (2022)

Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension
por: Tripathi, Dhiraj, et al.
Publicado: (2020)

Transjugular Intrahepatic Portosystemic Shunt Versus Surgical Shunting in the Management of Portal Hypertension
por: Huang, Long, et al.
Publicado: (2015)

Liver fibrosis promotes immunity escape but limits the size of liver tumor in a rat orthotopic transplantation model
por: Li, Tongqiang, et al.
Publicado: (2021)

Transjugular intrahepatic portal shunt in the treatment of portal hypertension due to cirrhosis: single center experience
por: Chen, Yun, et al.
Publicado: (2019)

The Transjugular Intrahepatic Portosystemic Shunt in the Treatment of Portal Hypertension: Current Status
por: Pomier-Layrargues, Gilles, et al.
Publicado: (2012)

A new choice of stent for transjugular intrahepatic portosystemic shunt creation: Viabahn ePTFE covered stent/bare metal stent combination
por: Liu, Jiacheng, et al.
Publicado: (2020)

Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy
por: Luo, Shi-Hua, et al.
Publicado: (2019)

Transjugular intrahepatic portosystemic shunt via left hepatic – left portal veins
por: Maleux, Geert
Publicado: (2019)

The role of transjugular intrahepatic portosystemic shunt in patients with portal hypertension: Advantages and pitfalls
por: Lee, Hae Lim, et al.
Publicado: (2022)

Advanced portal venous access techniques for transjugular intrahepatic portosystemic shunt placement
por: Partovi, Sasan, et al.
Publicado: (2021)

Transjugular intrahepatic portosystemic shunt for pediatric portal hypertension: A meta-analysis
por: Raissi, Driss, et al.
Publicado: (2023)

Development and Validation of Prognostic Models to Estimate the Risk of Overt Hepatic Encephalopathy After TIPS Creation: A Multicenter Study
por: Yang, Chongtu, et al.
Publicado: (2022)

Transjugular intrahepatic portosystemic shunt for repeated bleeding of hemorrhoids caused by severe portal hypertension with ectopic varices: A case report
por: Shi, Qin, et al.
Publicado: (2020)

Transjugular Intrahepatic Portosystemic Shunt for Maintenance of Portal Venous Patency in Liver Transplant Candidates
por: Gaba, Ron Charles, et al.
Publicado: (2013)

Transjugular Intrahepatic Portosystemic Shunt as the Treatment for Refractory Hepatic Hydrothorax with Portal Vein Thrombosis
por: Zhang, Lin-Hao, et al.
Publicado: (2017)

Portal Fibrotic Cord is Associated with Transjugular Intrahepatic Portosystemic Shunt Failure and Death in Cirrhotic Patients
por: Yang, Yunshu, et al.
Publicado: (2023)

Transjugular Intrahepatic Portosystemic Shunt Placement in Patients with Schistosomiasis-Induced Liver Fibrosis
por: Liu, Jiacheng, et al.
Publicado: (2019)

Increased Liquefactive Necrosis Formation After Transarterial Chemoembolization Combined with Molecular Targeted Agents Plus Immune Checkpoint Inhibitors for Hepatocellular Carcinoma
por: Wang, Yingliang, et al.
Publicado: (2021)

The Evolution of Transjugular Intrahepatic Portosystemic Shunt: Tips
por: Fanelli, Fabrizio
Publicado: (2014)

Parallel Shunt for the Treatment of Transjugular Intrahepatic Portosystemic Shunt Dysfunction
por: Luo, Xuefeng, et al.
Publicado: (2013)

Transsplenic portal vein reconstruction–transjugular intrahepatic portosystemic shunt in a patient with portal and splenic vein thrombosis
por: Salsamendi, Jason T., et al.
Publicado: (2016)

Incidence of portal vein thrombosis after splenectomy and its influence on transjugular intrahepatic portosystemic shunt stent patency
por: Dong, Fang, et al.
Publicado: (2019)

Transjugular intrahepatic portosystemic shunt with radioactive seed strand for main portal vein tumor thrombosis with cirrhotic portal hypertension
por: Yan, Xuan-Hui, et al.
Publicado: (2022)

Adverse events after the transjugular intrahepatic portal shunt are linked to serum metabolomic changes following the procedure
por: Chen, Quan, et al.
Publicado: (2023)

Anticoagulation after transjugular intrahepatic portosystemic shunt for portal hypertension: A systematic review and meta analysis
por: Jiao, Pan, et al.
Publicado: (2022)

Iodine-125 implantation with transjugular intrahepatic portosystemic shunt for main portal vein tumor thrombus
por: Zhang, Yue, et al.
Publicado: (2019)

Transjugular intrahepatic portosystemic shunt in the treatment of portal vein thrombosis: a critical review of literature
por: Qi, Xingshun, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_cmqohhdk9j712brknlo9qfp3ev